209 related articles for article (PubMed ID: 19376641)
21. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
22. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
Bian J; Dannappel M; Wan C; Firestein R
Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
[TBL] [Abstract][Full Text] [Related]
25. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
26. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling.
Hsieh A; Kim HS; Lim SO; Yu DY; Jung G
Cancer Lett; 2011 Jan; 300(2):162-72. PubMed ID: 20971552
[TBL] [Abstract][Full Text] [Related]
28. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
[TBL] [Abstract][Full Text] [Related]
29. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
[TBL] [Abstract][Full Text] [Related]
30. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
31. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
32. USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.
Novellasdemunt L; Foglizzo V; Cuadrado L; Antas P; Kucharska A; Encheva V; Snijders AP; Li VSW
Cell Rep; 2017 Oct; 21(3):612-627. PubMed ID: 29045831
[TBL] [Abstract][Full Text] [Related]
33. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
34. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
[TBL] [Abstract][Full Text] [Related]
35. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.
Savari S; Chandrashekar NK; Osman J; Douglas D; Bellamkonda K; Jönsson G; Juhas M; Greicius G; Pettersson S; Sjölander A
Carcinogenesis; 2016 May; 37(5):491-9. PubMed ID: 26979937
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
[TBL] [Abstract][Full Text] [Related]
38. α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes.
Choi SH; Estarás C; Moresco JJ; Yates JR; Jones KA
Genes Dev; 2013 Nov; 27(22):2473-88. PubMed ID: 24240237
[TBL] [Abstract][Full Text] [Related]
39. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.
Sierra J; Yoshida T; Joazeiro CA; Jones KA
Genes Dev; 2006 Mar; 20(5):586-600. PubMed ID: 16510874
[TBL] [Abstract][Full Text] [Related]
40. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.
Yang K; Popova NV; Yang WC; Lozonschi I; Tadesse S; Kent S; Bancroft L; Matise I; Cormier RT; Scherer SJ; Edelmann W; Lipkin M; Augenlicht L; Velcich A
Cancer Res; 2008 Sep; 68(18):7313-22. PubMed ID: 18794118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
